Table 1 Open in new tab US complete...

Site	All Ages^c	Children (0–14 y)^c	AYA (15–39 y)^c	Older Adult (40+ y)^c
Breast (female only)	2,829,041	914.57	0	0.00	39,084	37.23	2,789,956	1,949.00
Prostate (male only)	2,617,682	846.24	46	0.08	473	0.45	2,617,166	1,828.30
Colon and rectum	1,154,481	373.22	21	0.03	13,722	13.07	1,140,728	796.89
Melanoma of the skin	921,780	297.99	504	0.82	69,510	66.21	851,765	595.03
Corpus and uterus, NOS (female only)	600,346	194.08	0	0.00	6,244	5.95	594,103	415.03
Urinary bladder	563,640	182.21	131	0.21	4,330	4.12	559,180	390.63
Non-Hodgkin lymphoma	509,065	164.57	2,964	4.84	37,772	35.98	468,327	327.16
Lung and bronchus	399,431	129.13	104	0.17	3,592	3.42	395,735	276.45
Kidney and renal pelvis	341,505	110.40	5,275	8.62	18,293	17.43	317,937	222.10
Leukemia	287,963	93.09	22,429	36.65	56,761	54.07	209,773	146.54
Oral cavity and pharynx	275,193	88.96	423	0.69	10,857	10.34	263,911	184.36
Cervix uteri (female only)	249,496	80.66	22	0.04	18,668	17.78	230,806	161.24
Ovary (female only)	186,138	60.17	287	0.47	11,151	10.62	174,700	122.04
Hodgkin lymphoma	181,928	58.81	1,150	1.88	55,252	52.63	125,525	87.69
Primary brain tumors^b	147,220	47.59 ± 0.43	13,657	22.31	50,902	48.49 ± 0.69	82,661	57.75 ± 0.50
Larynx	89,029	28.78	0	0.00	480	0.46	88,550	61.86
Myeloma	77,617	25.09	0	0.00	852	0.81	76,764	53.63
Stomach	72,269	23.36	16	0.03	1,422	1.35	70,834	49.48
Pancreas	41,609	13.45	23	0.04	1,135	1.08	40,450	28.26
Liver and intrahepatic bile duct	41,404	13.39	1,418	2.32	2,272	2.16	37,713	26.35
Esophagus	33,839	10.94	0	0.00	270	0.26	33,569	23.45

Site	All Ages^c	Children (0–14 y)^c	AYA (15–39 y)^c	Older Adult (40+ y)^c
Breast (female only)	2,829,041	914.57	0	0.00	39,084	37.23	2,789,956	1,949.00
Prostate (male only)	2,617,682	846.24	46	0.08	473	0.45	2,617,166	1,828.30
Colon and rectum	1,154,481	373.22	21	0.03	13,722	13.07	1,140,728	796.89
Melanoma of the skin	921,780	297.99	504	0.82	69,510	66.21	851,765	595.03
Corpus and uterus, NOS (female only)	600,346	194.08	0	0.00	6,244	5.95	594,103	415.03
Urinary bladder	563,640	182.21	131	0.21	4,330	4.12	559,180	390.63
Non-Hodgkin lymphoma	509,065	164.57	2,964	4.84	37,772	35.98	468,327	327.16
Lung and bronchus	399,431	129.13	104	0.17	3,592	3.42	395,735	276.45
Kidney and renal pelvis	341,505	110.40	5,275	8.62	18,293	17.43	317,937	222.10
Leukemia	287,963	93.09	22,429	36.65	56,761	54.07	209,773	146.54
Oral cavity and pharynx	275,193	88.96	423	0.69	10,857	10.34	263,911	184.36
Cervix uteri (female only)	249,496	80.66	22	0.04	18,668	17.78	230,806	161.24
Ovary (female only)	186,138	60.17	287	0.47	11,151	10.62	174,700	122.04
Hodgkin lymphoma	181,928	58.81	1,150	1.88	55,252	52.63	125,525	87.69
Primary brain tumors^b	147,220	47.59 ± 0.43	13,657	22.31	50,902	48.49 ± 0.69	82,661	57.75 ± 0.50
Larynx	89,029	28.78	0	0.00	480	0.46	88,550	61.86
Myeloma	77,617	25.09	0	0.00	852	0.81	76,764	53.63
Stomach	72,269	23.36	16	0.03	1,422	1.35	70,834	49.48
Pancreas	41,609	13.45	23	0.04	1,135	1.08	40,450	28.26
Liver and intrahepatic bile duct	41,404	13.39	1,418	2.32	2,272	2.16	37,713	26.35
Esophagus	33,839	10.94	0	0.00	270	0.26	33,569	23.45

Table 1

US complete prevalence counts, invasive cancers only, 2010 by age at prevalence

Site	All Ages^c		Children (0–14 y)^c		AYA (15–39 y)^c		Older Adult (40+ y)^c
Site	Counts	Prevalence^a	Counts	Prevalence^a	Counts	Prevalence^a	Counts	Prevalence^a
Breast (female only)	2,829,041	914.57	0	0.00	39,084	37.23	2,789,956	1,949.00
Prostate (male only)	2,617,682	846.24	46	0.08	473	0.45	2,617,166	1,828.30
Colon and rectum	1,154,481	373.22	21	0.03	13,722	13.07	1,140,728	796.89
Melanoma of the skin	921,780	297.99	504	0.82	69,510	66.21	851,765	595.03
Corpus and uterus, NOS (female only)	600,346	194.08	0	0.00	6,244	5.95	594,103	415.03
Urinary bladder	563,640	182.21	131	0.21	4,330	4.12	559,180	390.63
Non-Hodgkin lymphoma	509,065	164.57	2,964	4.84	37,772	35.98	468,327	327.16
Lung and bronchus	399,431	129.13	104	0.17	3,592	3.42	395,735	276.45
Kidney and renal pelvis	341,505	110.40	5,275	8.62	18,293	17.43	317,937	222.10
Leukemia	287,963	93.09	22,429	36.65	56,761	54.07	209,773	146.54
Oral cavity and pharynx	275,193	88.96	423	0.69	10,857	10.34	263,911	184.36
Cervix uteri (female only)	249,496	80.66	22	0.04	18,668	17.78	230,806	161.24
Ovary (female only)	186,138	60.17	287	0.47	11,151	10.62	174,700	122.04
Hodgkin lymphoma	181,928	58.81	1,150	1.88	55,252	52.63	125,525	87.69
Primary brain tumors^b	147,220	47.59 ± 0.43	13,657	22.31	50,902	48.49 ± 0.69	82,661	57.75 ± 0.50
Larynx	89,029	28.78	0	0.00	480	0.46	88,550	61.86
Myeloma	77,617	25.09	0	0.00	852	0.81	76,764	53.63
Stomach	72,269	23.36	16	0.03	1,422	1.35	70,834	49.48
Pancreas	41,609	13.45	23	0.04	1,135	1.08	40,450	28.26
Liver and intrahepatic bile duct	41,404	13.39	1,418	2.32	2,272	2.16	37,713	26.35
Esophagus	33,839	10.94	0	0.00	270	0.26	33,569	23.45

Site	All Ages^c		Children (0–14 y)^c		AYA (15–39 y)^c		Older Adult (40+ y)^c
Site	Counts	Prevalence^a	Counts	Prevalence^a	Counts	Prevalence^a	Counts	Prevalence^a
Breast (female only)	2,829,041	914.57	0	0.00	39,084	37.23	2,789,956	1,949.00
Prostate (male only)	2,617,682	846.24	46	0.08	473	0.45	2,617,166	1,828.30
Colon and rectum	1,154,481	373.22	21	0.03	13,722	13.07	1,140,728	796.89
Melanoma of the skin	921,780	297.99	504	0.82	69,510	66.21	851,765	595.03
Corpus and uterus, NOS (female only)	600,346	194.08	0	0.00	6,244	5.95	594,103	415.03
Urinary bladder	563,640	182.21	131	0.21	4,330	4.12	559,180	390.63
Non-Hodgkin lymphoma	509,065	164.57	2,964	4.84	37,772	35.98	468,327	327.16
Lung and bronchus	399,431	129.13	104	0.17	3,592	3.42	395,735	276.45
Kidney and renal pelvis	341,505	110.40	5,275	8.62	18,293	17.43	317,937	222.10
Leukemia	287,963	93.09	22,429	36.65	56,761	54.07	209,773	146.54
Oral cavity and pharynx	275,193	88.96	423	0.69	10,857	10.34	263,911	184.36
Cervix uteri (female only)	249,496	80.66	22	0.04	18,668	17.78	230,806	161.24
Ovary (female only)	186,138	60.17	287	0.47	11,151	10.62	174,700	122.04
Hodgkin lymphoma	181,928	58.81	1,150	1.88	55,252	52.63	125,525	87.69
Primary brain tumors^b	147,220	47.59 ± 0.43	13,657	22.31	50,902	48.49 ± 0.69	82,661	57.75 ± 0.50
Larynx	89,029	28.78	0	0.00	480	0.46	88,550	61.86
Myeloma	77,617	25.09	0	0.00	852	0.81	76,764	53.63
Stomach	72,269	23.36	16	0.03	1,422	1.35	70,834	49.48
Pancreas	41,609	13.45	23	0.04	1,135	1.08	40,450	28.26
Liver and intrahepatic bile duct	41,404	13.39	1,418	2.32	2,272	2.16	37,713	26.35
Esophagus	33,839	10.94	0	0.00	270	0.26	33,569	23.45

^a Rates are per 100000 and age-adjusted to the 2010 US standard population.

^b US 2010 cancer prevalence counts are based on the 2010 cancer prevalence proportions from CBTRUS 1995–2011 and statistical analyses from the SEER 9 registries.

^c Due to rounding, the sum of the age specific estimates may not equal the all ages estimate.

Listed cancer sites are ordered by 2010 prevalence estimates.

US 2010 cancer prevalence counts are based on 2010 cancer prevalence proportions from the SEER 9 registries (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta) on 1/1/2010.

US population estimates are based on the average of 2009 and 2010 populations.

Cases diagnosed more than 35 years ago were estimated using the completeness index method (Capocaccia et al, 1997; Merrill et al, 2000).

NOS, not otherwise specified.

This Feature Is Available To Subscribers Only